| Literature DB >> 25243158 |
Daliborka Dušanić1, Dušan Benčina1, Mojca Narat1, Irena Oven1.
Abstract
In infectious synovitis caused by Mycoplasma synoviae chicken chondrocytes (CCH) may come into direct contact with these bacteria that are also capable of invading CCH in vitro. In this study, phenotype microarrays were used to evaluate the influence of Mycoplasma synoviae on the global metabolic activity of CCH. Therefore, CCH were cultured in the presence of 504 individual compounds, spotted in wells of 11 phenotype microarrays for eukaryotic cells, and exposed to Mycoplasma synoviae membranes or viable Mycoplasma synoviae. Metabolic activity and sensitivity of normal cells versus infected cells were evaluated. Metabolic profiles of CCH treated with viable Mycoplasma synoviae or its membranes were significantly different from those of CCH alone. CCH treated with Mycoplasma synoviae membranes were able to use 48 carbon/nitrogen sources not used by CCH alone. Treatment also influenced ion uptake in CCH and intensified the sensitivity to 13 hormones, 5 immune mediators, and 29 cytotoxic chemicals. CCH were even more sensitive to hormones/immune mediators when exposed to viable Mycoplasma synoviae. Our results indicate that exposure to Mycoplasma synoviae or its membranes induces a wide range of metabolic and sensitivity modifications in CCH that can contribute to pathological processes in the development of infectious synovitis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25243158 PMCID: PMC4160629 DOI: 10.1155/2014/613730
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Optimization of formazan production by CCH. CCH were plated in complete medium or MC-0 medium at indicated number of cells per well and incubated with Biolog Redox dye mix MA or MB for 6 hours. The background signal (medium incubated with appropriate dye, but with no cells) was subtracted from the data.
Figure 2An example of the compared carbon source metabolic activities of CCH and CCH exposed to M. synoviae WVU 1853 membrane fraction (MSm) in PMM 1 containing different carbon and nitrogen sources. Kinetic data were collected using the Biolog Omnilog instrument and software. The curves show the time course (horizontal axis) of the amount of purple colour formed from tetrazolium dye reduction (vertical axis) in each of the 96 wells. All respiratory signals were previously corrected to the respiration of CCH in well A1, containing no supplements. Data from CCH are shown in red, from CCH+MSm in green, and yellow is the overlapping of the two kinetic curves. Wells where differences between respiratory signals reached a cutoff value (>500) are encircled white and are of two types: (i) C sources more rapidly metabolized by CCH compared to CCH+MSm are shown in red (A12, b-gentibiose); (ii) C sources more rapidly metabolized by CCH+MSm compared CCH are shown in green (C5, D-mannose). Wells that are not encircled represent compounds where metabolism was not detected or are metabolized equally both in CCH and CCH+MSm and are shown in yellow (C4, mannan; C10, sucrose).
Metabolic and sensitivity profiles of CCH and CCH exposed to M. synoviae WVU 1853 membrane fraction.
| C/N sources | CCH25 1 | CCH25+MSm2 | Cytotoxic/anti-cancer agents | CCH25 1 | CCH25+MSm2 |
|---|---|---|---|---|---|
| 2,3-butanediol | − | + | 12,4′-demethylepipodophyllotoxin | − | + |
| Acetic acid | − | + | Acivicin | − | + |
| a-D-glucose | + | ↑ | Aclarubicin | − | + |
| a-D-glucose-1-phosphate | − | + | Aklavine hydrochloride | − | + |
| Adonitol | − | + | Beta-peltatin | − | + |
| a-Hydroxy-butyric acid | − | + | Carmofur | + | − |
| a-Keto-glutaric acid | + | ↑ | Celastrol | − | + |
| a-Methyl-D-glucoside | + | = | Cepharanthine | − | + |
| a-Methyl-D-mannoside | + | = | Chloroquine diphosphate | − | + |
| b-Gentiobiose | + | − | Colchicine | − | + |
| b-Methyl-D-galactoside | − | + | Cytosine-beta-d-arabinofuranoside | − | + |
| b-Methyl-D-glucoside | − | + | Dactinomycin | − | + |
| b-Methyl-D-xylopyranoside | − | + | Daunorubicin hydrochloride | − | + |
| Chondroitin-6-sulfate | + | ↑ | Doxorubicin hydrochloride | − | + |
| D,L-b-Hydroxy-butyric acid | − | + | Elaidylphosphocholine | − | + |
| D,L-Lactic acid | + | ↑ | Emetine | − | + |
| D-Arabinose | − | + | Gossypol | − | + |
| D-Cellobiose | + | = | Indole-3-carbinol | − | + |
| Dextrin | − | + | Mercaptopurine | + | ↑ |
| D-Fructose | − | + | Mitoxantrone hydrochloride | − | + |
| D-Fructose-6-phosphate | + | = | Nocodazole | − | + |
| D-Fucose | − | + | Perillyl alcohol | + | ↑ |
| D-Glucosaminic acid | − | + | Piceatannol | − | + |
| D-Glucose-6-phosphate | + | ↑ | Picropodophyllotoxin | − | + |
| D-Lactitol | − | + | Podofilox | − | + |
| D-Maltose | + | ↑ | Quercetin dihydrate | − | + |
| D-Mannitol | − | + | Quinacrine hydrochloride | − | + |
| D-Mannose | − | + | Rapamycin | − | + |
| D-Melezitose | − | + | Rifaximin | + | − |
| D-Raffinose | + | = | Rotenone | − | + |
| D-Tagatose | − | + | Vinblastine sulfate | − | + |
| D-Trehalose | + | = | |||
| g-Amino-N-butyric acid | − | + |
| ||
| g-Hydroxy-butyric acid | − | + | Ammonium chloride | + | − |
| Glycogen | + | ↑ | Ferric chloride | + | ↑ |
| Hexanoic acid | − | + | Iodine | + | − |
| Lactulose | − | + | Lithium chloride | + | = |
| L-Glucose | − | + | Magnesium chloride | + | + |
| L-Glutamine | − | + | NaCl | + | − |
| L-Rhamnose | − | + | Potassium chloride | + | − |
| Malitol | + | = | Potassium chromate | + | − |
| Maltotriose | + | ↑ | Sodium molybdate | + | − |
| Melibionic acid | − | + | Sodium nitrate | + | − |
| Meso-tartaric acid | − | + | Sodium nitrite | + | − |
| Mono-methylsuccinate | − | + | Sodium pyrophosphate | + | − |
| Myo-inositol | − | + | Sodium sulfate | + | − |
| N-Acetyl-b-D-mannosamine | − | + | Zinc chloride | + | − |
| N-Acetyl-D-glucosamine | − | + | |||
| N-Acetylneuraminic acid | − | + | |||
| Pectin | − | + | |||
| Stachylose | − | + | |||
| Succinamic acid | − | + | |||
| Sucrose | + | = | |||
| Tricarballylic acid | − | + | |||
| 18 dipeptides3 | + | − | |||
| 10 dipeptides4 | + | = | |||
| 3 dipeptides5 | + | ↑ | |||
| 11 dipeptides6 | − | + |
1Respiration levels for CCH incubated for 25 h (CCH25) were determined by comparing respiratory rates of CCH in each well of a plate to the corresponding A1 well that contained no supplements (+ respiration was higher than in A1).
2Respiration levels for CCH exposed to M. synoviae WVU 1853 membrane fraction (1 mg/mL, 15 µL/well for 5 h before the measurement started) were determined by comparing respiratory rates measured during 24 h to those of CCH25.
3Dipeptides: Asn-Glu, Asp-Glu, Glu-Ala, Glu-Asp, Gln-Glu, Gly-Ala, Gly-Arg, Met-Trp, Phe-Ile, Phe-Val, Pro-Glu, Pro-Gln, Ser-Tyr, Thr-Pro, Thr-Ser, Trp-Val, Val-Phe, and Val-Ser.
4Dipeptides: Asp-Trp, Asp-Val, Glu-Ser, Glu-Tyr, Glu-Val, Gln-Gly, Tyr-Gln, Tyr-Glu, Tyr-Tyr, and Val-Lys.
5Dipeptides: Asp-Phe, Gln-Gln, and Gly-Asp.
6Dipeptides: Ala-Val, Arg-Trp, Arg-Tyr, Asp-Gly, Gly-Ser, Phe-Asp, Tyr-Val, Val-Ala, Val-Asn, Val-Gln, and Val-Gly.
Legend:
+: Respiration above cut-off value set to 500 (area under corresponding graph: for CCH compared to A1, for CCH+MSm compared to CCH).
−: Respiration lower than 500.
↑: Respiration of CCH+MSm higher than respiration of CCH in the presence of the same compound.
↓: Respiration of CCH+MSm lower than respiration of CCH in the presence of the same compound.
=: Respiration present in both CCH and CCH+MSm, difference not significant.
Sensitivity of CCH and M. synoviae WVU 1853 infected CCH to hormones and immune mediators.
| Hormone/immune mediator | CCH25 1 | CCH44 1 | CCH + MSm25 2 | CCH + MS44 3 |
|---|---|---|---|---|
| 3-Isobutyl-1-Methylxanthine | − | + | − | +/= |
| 4,5-a-Dihydrotestosterone | − | − | + | + |
| Adenosine | + | + | + | +/↑ |
| Adrenocorticotropic Hormone Human (ACTH) | − | + | +/= | +/↑/= |
| Aldosterone | + | − | + | + |
|
| − | − | + | + |
| Caffeine | − | + | − | +/↑ |
| Calcitonin | − | − | − | + |
| Calcitriol (1a,25-dihydroxyvitamin D3) | − | − | − | + |
| Chorionic Gonadotropin Human (HCG) | − | + | − | +/=/↓/↑ |
| Creatine | − | − | − | + |
| Dexamethasone | − | − | + | + |
| Dibutyryl-cAMP | − | − | − | + |
| Epinephrine | − | + | − | +/↓ |
| FGF-1 (aFGF) | − | − | + | + |
| Gastrin | − | − | − | + |
| Ghrelin | − | − | − | + |
| Gly-His-Lys acetate salt | − | + | + | +/↑ |
| hGH (Somatotropin) | − | − | + | + |
| Hydrocortisone | + | − | +/= | + |
| IGF-I | − | − | − | + |
| Insulin | − | − | + | + |
| L-leucine | − | + | − | +/↑ |
| Luteinizing Hormone (LH) | − | + | − | +/↓/↑ |
| Luteinizing Hormone Releasing Hormone (LH-RH) | − | + | − | +/↑/↓ |
| Norepinephrine | − | − | − | + |
| Parathyroid Hormone | − | + | − | +/= |
| PDGF-AB | − | − | − | + |
| Progesterone | + | − | + | + |
| Prolactin | − | + | − | +/↓/=/↑ |
| Resistin | − | + | + | +/= |
| Thyrotropic Hormone (TSH) | − | + | + | +/↓ |
| Thyrotropin Releasing Hormone acetate salt (TRH) | − | + | − | +/= |
| Thyroxine | − | − | + | + |
| Triiodothyronine | − | + | + | +/↑ |
| Vasopressin | − | + | + | +/↓/= |
| IL-1 | − | − | − | + |
| IL-2 | − | + | + | +/↓ |
| IL-6 | − | − | + | + |
| IL-8 | − | + | + | + |
| TNF-α | − | + | + | +/↑ |
| IFN- | − | + | + | +/= |
1Respiration levels for CCH incubated for 25 h (CCH25) or 44 h (CCH44) were determined by comparing respiratory rates of CCH in each well of a plate to the corresponding A1 well that contained no supplements. (+ respiration was higher than in A1).
2Respiration levels for CCH exposed to M. synoviae WVU 1853 membrane fraction (1 mg/mL, 15 µL/well for 5 h before the measurement started) were determined by comparing respiratory rates measured during 24 h to those of CCH25.
3Respiration levels for CCH infected with live M. synoviae WVU 1853 (107 CFU/well for 14 h before the measurement started) were determined by comparing respiratory rates measured during 24 h to those of CCH44.
Legend:
+: Respiration above cut-off value set to 500 in at least one concentration of hormone/cytokine (area under corresponding graph: for CCH compared to A1, for CCH+MSm/CCH+MS compared to CCH).
−: Respiration lower than 500.
+/=; +/↑; +/↓: Respiration was detected and was, compared to respiration in CCH, equal, higher, or lower at different concentrations of hormones/cytokines.
Figure 3Sensitivity of CCH and CCH exposed to M. synoviae WVU 1853 whole cells or membranes as a function of cytokine concentration and time of exposure. 1 CCH25—respiratory activity of noninfected chicken chondrocytes exposed to cytokines for 25 h. 2 CCH44—respiratory activity of noninfected chicken chondrocytes exposed to cytokines for 44 h. 3MSm—Mycoplasma synoviae WVU 1853 membrane fraction. 4MS—Mycoplasma synoviae WVU 1853 live culture. *Different strength of respiratory activity signal is depicted in different shades of red.